当前位置：
X-MOL 学术
›
Lancet Respir. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics.
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2020-02-13 , DOI: 10.1016/s2213-2600(20)30071-0 Jinnong Zhang 1 , Luqian Zhou 2 , Yuqiong Yang 2 , Wei Peng 3 , Wenjing Wang 1 , Xuelin Chen 4
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2020-02-13 , DOI: 10.1016/s2213-2600(20)30071-0 Jinnong Zhang 1 , Luqian Zhou 2 , Yuqiong Yang 2 , Wei Peng 3 , Wenjing Wang 1 , Xuelin Chen 4
Affiliation
|
In December, 2019, numerous unexplained pneumonia cases occurred in Wuhan, China. This outbreak was confirmed to be caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), belonging to the same family of viruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). The SARS epidemic in 2003 was controlled through numerous measures in China. One effective strategy was the establishment of fever clinics for triaging patients. Based on our first-hand experience in dealing with the present outbreak in Wuhan, we have established the following clinical strategies in adult fever clinics ().
更新日期：2020-03-03
京公网安备 11010802027423号